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INTRODUCTION 
Adenotonsillar disease is a common paediatric 
otorhinolaryngolocal disorder worldwide.
1
 The disorder 
affects the upper respiratory tract.
2
 
The tonsils are lymphoepithelial tissues located at the 
entrance of the upper aerodigestive tract.
4
 They consist of 
the nasopharyngeal (adenoid), palatine, lingual, posterior 
and lateral pharyngeal wall parts. Together, they form the 
Waldeyer’s ring.3 Embryologically, they develop from 
the epithelium of the primitive oronasal cavity, 
mesenchymal stroma and lymphoid cells. The tonsils 
increase rapidly in size between the first and third year of 
life with peaks in the third and seventh year.
5
 They 
involute slowly before early puberty and finally disappear 
before the age of 20 years. The main cellular component 
of tonsils is B-lymphocyte while T-cell lymphocytes 
constitute about 40% of its total volume. It produces 
antibodies, lymphokines and gamma interferon. These 
induce cellular immunity.
6
 
ABSTRACT 
 
Background: Adenotonsillar hypertrophy is a common paediatric disorder in Otorhinolaryngological practice 
worldwide. The prevalence, clinical manifestations and predisposing factors are well documented in developed 
countries. However, available data shows differences between the various studies. There is paucity of data from 
developing countries. Thus, this study is aimed at assessing the age group distribution, predisposing factors, clinical 
manifestation and complications of adenotonsillar hypertrophy in a developing country.  
Methods: It is a prospective study of children under 10 years over a period of 24 months. Interviewer assisted 
questionnaire was administered. Data obtained were statistically analysed using SPSS version 18.   
Results: Two hundred and fifty three, 253 subjects were enrolled into the study. Adenotonsillar hypertrophy affected 
all age groups studied. A high incidence was noted among the under 2 year olds. The Male: Female ratio was 2:1. 
Chronic cases constituted 55.7% of our study population. Common predisposing factors were atopy (73.9%), familial 
history (67.3%) and recurrent upper respiratory tract infection (58.2%). The Commonest clinical features were 
snoring, noisy breathing, tonsillar enlargement and narrowing of postnasal space air column. Failure to thrive, otitis 
media and rhinosinusitis were the commonly associated complications observed. No death was recorded.  
Conclusions: Adenotonsillar hypertrophy is common in our environment. It is important for all primary health care 
physicians, paediatricians and otorhinolaryngologists to have a clear knowledge on this ailment. Prevention or 
reduction in incidence is possible.  
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Common disorders of tonsils in the paediatric age group 
are obstructive hypertrophy and infection of the tonsils 
from viral or bacterial agents.
7
 Obstructive hypertrophy 
results from increase in immunologic activity while 
infection of the tonsils leads to inflammation of tonsillar 
tissue.
8,9
 Hypertrophic tonsils may be acute or chronic 
and account for about 80% of obstructive sleep apnoea in 
children.
10
 
Severe forms of obstructive sleep apnoea due to 
adenotonsillar hypertrophy may be complicated by 
pneumonia, cor pulmonale, pulmonary hypertension, 
chronic hypercapnia or hypoxia and right heart failure.
11-
13
 However, adenotonsillar hypertrophy has been reported 
to more commonly cause acute and chronic otitis media, 
rhinosinusitis, maldevelopment of upper jaw and poor 
physical and mental development due to chronic 
hypoxia.
14
 
For proper assessment, good history of presenting 
symptoms such as mouth, breathing, noisy breathing, 
snoring, frequent awake from sleep, enuresis, nightmares, 
hypersomnolence, feeding habit and academic 
performance must be taken.
15,16
  
Findings on examination include adenoid faces, flattened 
nasolabial fold, pinched nose, protruding upper incisor, 
small for age, enlarged tonsil etc. Lateral x-ray soft tissue 
of head and neck region, chest x-ray and 
electrocardiogram are done to confirm diagnosis and rule 
out complications.
17
 
There is paucity of literature on this common ailment in 
developing countries. Thus this study is aimed at 
determining the age group distribution, clinical 
presentation, predisposing factors and complications in 
our environment. 
METHODS 
This is a prospective hospital based study carried out in 
Ekiti State University Teaching Hospital, Ado Ekiti, 
Nigeria between November 2014 and December 2016. 
All consecutive patients with symptoms suggestive of 
adenotonsillar hypertrophy were clinically evaluated by a 
detailed history. General examination and specific 
examination of ear, nose, throat, central nervous system, 
respiratory system and cardiovascular system were also 
done. Relevant investigations include radiological chest 
x-ray, x-ray postnasal space, electrocardiogram and 
echocardiogram were performed. 
Informed consent was obtained from the parents or 
guardians before subject enrolment.  
Inclusion criteria include, patients with either obstructive 
adenoid enlargement, tonsillar hypertrophy or both whose 
parents /guardians gave consent to participate in the 
study. 
Exclusion criteria were those above 10 years of age, 
patients with craniofacial anomalies and patients with 
acute upper respiratory tract infection. 
An Interviewer’s assisted study form was used to collect 
data. The data collected include the following. 
1. Demographic information 
2. Presenting complaints. 
3. Associated symptoms. 
4. Frequency of tonsil infections 
5. Otologic symptoms 
6. Nasal symptoms 
7. Respiratory symptoms 
8. History of similar symptoms among the siblings. 
9. History of allergy. 
10. First source of health attention. 
11. Physical findings on general examination and 
examination of the ears, nose and throat.  
12. Radiologic findings 
13. Electro and Echocardiographic findings. 
Data obtained were collated on an excel spread sheet and 
those who met the inclusion criteria were grouped into 
age groups, clinical presentations, predisposing factors 
and complications. These were statistically analyzed. 
Ethical clearance was sought for this study and was 
obtained from ethical committee of our institution.  
RESULTS 
The total number of children who were enrolled into the 
study was 253. One hundred and sixty nine (66.8%) were 
males while eighty-four (33.2%) were females with a 
Male: Female ratio of 2:1.  
Table 1: Age group distribution of the patients. 
Age group 
(in years) 
Number of 
patients 
Pathology 
0-2 126 Adenoid only 
2-4 61 Adenoid and Tonsils 
4-6 27 Adenoid and Tonsils 
6-8 22 Adenoid and Tonsils 
8-10 17 Adenoid and Tonsils 
Total 253  
Table 1 shows the age group distribution of the patients. 
The disorder was seen in all the studied age groups.  
Figure 1 shows the pattern of presentation of the patients. 
89.7% of the patients were seen in the outpatient clinic 
and 10.3% were seen in the children emergency.  
The order in which the parents or guardians sought for 
the first medical care is shown in Table 2 were family 
physicians, 54.5%; paediatricians, 36.4% then ear, nose 
and throat surgeons, 9.1%. 
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Figure 1: Mode of presentation in hospital. 
Table 2: Pattern of seeking first medical care. 
First medical care Percentage (%) 
Family physician 54.5 
Paediatrician 36.4 
Otorhinolaryngologist  9.1  
Total  100 
 
Figure 2: Predisposing factors. 
Figure 2 illustrates the common predisposing factors with 
atopy as the commonest 73.9%.  
 
Figure 3: Clinical features. 
The pattern of common clinical features is illustrated in 
Figure 3 with snoring and gross narrowing of the 
nasopharyngeal air column on x-ray noted in over 95% of 
the patients.  
 
Figure 4: Complications of adenotonsilar 
hypertrophy. 
Figure 4 illustrates the complications seen among the 
patients with failure to thrive seen in 82.5% of the 
patients. 
DISCUSSION 
The results of this study showed that Adenotonsillar 
hypertrophy was found among all the children studied. 
This is similar to findings in other studies.
18
 
Adenotonsillar hypertrophy was found to be most 
predominant among pre-school children in most previous 
studies. It is adduced that at this age group, the tonsils 
and adenoid are in their largest size in relation to the 
underlying airway size.
19,20
 In this study, adenotonsillar 
enlargement was most prevalent below the age of 2 years. 
This finding could be due to high incidence of upper 
respiratory tract infections in the study area.
21
 
Adenotonsillar hypertrophy is mainly a disease of the 
children. 
In this study, there is a male preponderance.
22
 Other 
research works showed equal affectation of females and 
males. While some studies found a female 
preponderance, others have also shown a male 
preponderance. Thus, it can be inferred that both sexes 
are at risk. However, males are more playful and may be 
more predisposed to recurrent upper respiratory tract 
infections.  
Adenotonsillar hypertrophy has been reported to be due 
to persistent inflammation of tonsillar tissue with 
resultant hyperplasia.
23,24
 This leads to marked 
obstructive symptoms as expressed in the studied 
patients. Marked nasal obstruction results in alternative 
mouth opening for airflow into the pharynx. Marked 
obstruction with associated cerebral hypoxia leads to 
muscular hypotonicity. This leads to turbulence in air 
flow with resultant snoring and/or noisy breathing.
22
 
Airway collapse leads to intermittent apnoeic attack. 
These findings were recorded in our study findings. 
Out 
patients 
clinic 
90% 
Emergency 
department 
10% 
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The X-ray findings in this study also reveal that a 
significant number of the patients had adenoid 
enlargement. This is confirmed by narrowing of the 
nasopharyngeal air column between an increased soft 
tissue mass density from the bony cervical spine with 
body of the sphenoid bone and palate below. 
This study shows marked reactive and infective 
background among the studied population. The high 
incidence of recurrent infection, atopy, and family history 
of adenotonsilar hypertrophy had also been noted in other 
studies.
25
 
Adenotonsillar hypertrophy with the resulting obstructive 
sleep apnoea syndrome when untreated can lead to 
serious morbidity. Some studies revealed high incidence 
of serious complications such as failure to thrive, 
corpulmonale with pulmonary hypertension due to 
obstructive sleep apnoea syndrome and mental 
retardation with poor academic performance due to 
chronic brain hypoxia.
26
 These untoward effects of 
adenotonsillar hypertrophy are rare as evidenced in this 
study. The exception is failure to thrive which is 
common. This may be due to self-medication of upper 
respiratory tract infections or fever. Death as 
complication is very rare and not seen in this study 
population. 
CONCLUSION  
Adenotonsillar hypertrophy is a otorhinolaryngological 
disorder common in our environment. It is common in 
children that all primary health care physicians, 
paediatricians and otorhinolaryngologists should have a 
good knowledge on this ailment. This disease burden can 
be prevented or reduced. Incidence of the associated 
complication can be abolished. 
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